...
首页> 外文期刊>Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca: Veterinary Medicin >Computational Study of Interspecies TOP2A Similarities for Further Development of New Double Targeted Therapeutic Immunoconjugates
【24h】

Computational Study of Interspecies TOP2A Similarities for Further Development of New Double Targeted Therapeutic Immunoconjugates

机译:种间TOP2A相似性的计算研究,用于进一步开发新型双靶向治疗性免疫缀合物

获取原文
           

摘要

Targeted therapies are a growing research area with important implications inveterinary and human health. DNA topoisomerase 2-alpha (TOP2A) is over-expressed inhighly proliferative cells and represents the molecular target of the anticancer quinones(anthracycline antibiotics and naphthoquinones). The purpose of this study is to identifyinterspecies TOP2A similarities as possible epitopes for further development of therapeuticimmunoconjugates with multiple species reactivity: Mus musculus (Ms), Rattus norvegicus(R) and Homo sapiens (H). The main idea is to make possible testing the same therapeuticimmunoconjugates (with various quinones as active substance) on main species used aslaboratory animals before clinical trials. Moreover, in this case, TOP2A acts as double target:first as epitope for a specific antibody and second as molecular target for quinones. This paperused NCBI Reference Sequences and NCBI Blastp Suite to finds regions of similaritybetween protein sequences of H-TOP2A (NP_001058.2) as query sequence, and Ms-TOP2A(NP_035753.2) and R-TOP2A (NP_071519.2) as blasts hits. An overview of the two blastsequences aligned to the query sequence is shown in Fig. 1.Results and colour-codes indicate that both blast hits are in the range of bestalignments with query sequence. Reliabilities of alignments are high predicting goodsimilarities between structures of the three isomerases. It is highly probable that quinoneshave inhibitor activities on all three species and antibody to have interspecies reactivity.Acknowledgments. This study has been financed by Romanian Ministry of Educationand Research, National Authority for Scientific Research, National Centre for ProgrammesManagement on Grant Agreement no. 61-002/2007 (Project no. 1885/2007): Obtaining andcharacterization of new targeted-nanodrugs with naphthoquinonic active substance.
机译:靶向疗法是一个正在发展的研究领域,对兽医和人类健康具有重要意义。 DNA拓扑异构酶2-alpha(TOP2A)在高度增殖的细胞中过度表达,代表抗癌醌(蒽环类抗生素和萘醌)的分子靶标。这项研究的目的是将种间TOP2A相似性鉴定为可能的表位,以进一步开发具有多种反应性的治疗性免疫偶联物:小家鼠(Ms musculus),小家鼠(Rattus norvegicus)和智人(Homo sapiens)(H)。主要思想是在临床试验之前,可以对用于实验室动物的主要物种测试相同的治疗性免疫偶联物(以各种醌类为活性物质)。而且,在这种情况下,TOP2A充当双重靶标:首先充当特定抗体的表位,其次充当醌的分子靶标。本文使用NCBI参考序列和NCBI Blastp Suite查找作为查询序列的H-TOP2A(NP_001058.2)和Ms-TOP2A(NP_035753.2)和R-TOP2A(NP_071519.2)的蛋白质序列之间的相似性区域。 。与查询序列比对的两个blast序列的概述如图1所示。结果和颜色代码表明两个blast命中均在与查询序列的最佳比对范围内。比对的可靠性高预测了三种异构酶的结构之间的良好相似性。极有可能醌抑制剂在所有三个物种上均具有活性,并且抗体具有种间反应性。这项研究是由罗马尼亚教育和研究部,国家科学研究总局,国家计划管理中心(根据第25号赠款协议)资助的。 61-002 / 2007(项目编号1885/2007):获得并表征了带有萘醌活性物质的新型靶向纳米药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号